SCHEMBL30755352

SCHEMBL30755352

COC(=O)c1ccc(C2CCNCC2)c(OC2CCCCC2)c1

nearest known ligand 0.51

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 12/20 0.45
PDE4B Q07343 12/20 0.44
PDE5A O76074 2/20 0.44
PDE4A P27815 10/20 0.44
PDE4C Q08493 10/20 0.44
PDE1A P54750 1/20 0.43
PDE1B Q01064 1/20 0.43
PDE1C Q14123 1/20 0.43
CHRNB2 P17787 1/20 0.42
CHRNA4 P43681 1/20 0.42
MAPK14 Q16539 1/20 0.41
ALDH1A1 P00352 1/20 0.41
ATM Q13315 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27372087 1.00 PDE4D (0.45) PDE4DPDE4BPDE5APDE4APDE4C
SCHEMBL72571 0.79 NOTUM (0.48) PDE4DPDE4BPDE4APDE4C
SCHEMBL27372074 0.79 PDE4B (0.56) PDE4DPDE4BPDE4APDE4C
SCHEMBL30755183 0.79 PDE4B (0.56) PDE4DPDE4BPDE4APDE4C
Hydrochloric Acid SCHEMBL72570 0.78 NOTUM (0.47) PDE4DPDE4BPDE4APDE4C
SCHEMBL27372082 0.77 PDE4D (0.52) PDE4DPDE4BPDE5APDE4APDE4C
SCHEMBL5309884 0.77 PDE4D (0.67) PDE4DPDE4BPDE5APDE4APDE4C
SCHEMBL7364684 0.77 PDE4D (0.60) PDE4DPDE4BPDE5APDE4APDE4C
SCHEMBL7355374 0.77 CA12 (0.54) PDE4DPDE4BPDE5APDE4APDE4C
SCHEMBL17397553 0.76 CHRNB2 (0.46) CHRNB2CHRNA4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4562016-A2 CDK2 INHIBITORS AND METHODS OF USING THE SAME Cedilla Therapeutics, Inc. (US) 2025-06-04 EP disclosed
WO-2024026483-A2 CDK2 INHIBITORS AND METHODS OF USING THE SAME CEDILLA THERAPEUTICS, INC. (US) 2024-02-01 WO disclosed